The Woolcock Institute of Medical Research strives to improve respiratory and sleep health globally through world-class research, clinical care and education.
Our team of more than 200 medical researchers is dedicated to investigating the causes of disease, finding better treatments and translating our discoveries into new clinical practice.
Our approach is holistic, from basic scientific research into the mechanisms of disease through to the development of high-tech applications and inhalers for the front line. Our work involves clinical investigation of new therapies and innovative approaches to patient management as well as implementation research to improve the uptake of our evidence. We also study large patient populations to determine the best public health strategies for respiratory health in our community.
We are determined that our work creates a better life for people living with lung and respiratory conditions and sleep disorders. Our dedication to wellbeing is at the very heart of what we do.
Improved quality of life for individuals and families affected by sleep, breathing and lung disorders.
The Woolcock Institute of Medical Research (the Woolcock) aspires to maintain our world leading research impact by the translation of sleep, respiratory and lung cancer research into better clinical outcomes globally.
Currently ranked as the leading Australian sleep and respiratory research institute, the Woolcock is a globally renowned network of researchers and clinicians who deal with the causes, prevention, diagnosis and treatment of respiratory disease and sleep disorders.
The Institute has strong affiliations with many organisations including the University of Sydney, the University of Technology Sydney (UTS), UNSW Sydney, Sydney Local Health District, Northern Sydney Local Health District, National Lung Hospital in Hanoi, Vietnam and several other major health districts, health care provider networks, professional bodies, commercial companies and research funding organisations.
In addition, the Woolcock’s scientists and clinicians collaborate with colleagues across Australia, Asia, Europe and North America. We also operate a branch office in Vietnam (Woolcock Vietnam).
Each of our five strategic objectives is supported by a comprehensive set of actions and initiatives as detailed in our Strategic Plan 2019-2021.
Performance against each of the five strategic objectives is monitored by the Board and Management against a number of Key Performance Indicators (KPIs), each of which sets a three-year target to be achieved over the life of the plan.